GTG company logo final.png

Genetic Technologies

(ASX:GTG)

Genetic Technologies Company Overview

Genetic Technologies (ASX:GTG) Limited offers predictive testing and assessment tools to help physicians proactively manage women’s health. The Company’s lead product,BREVAGenplus®, is a clinically validated risk assessment test for non-hereditary breast cancer and is first in its class.



Genetic Technologies Market Data


Thanks for subscribing!

X